Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb 10;90(2):282-9.
doi: 10.1016/j.ajhg.2011.11.023. Epub 2012 Jan 19.

Mutations in KAT6B, encoding a histone acetyltransferase, cause Genitopatellar syndrome

Philippe M Campeau  1 , Jaeseung C Kim, James T Lu, Jeremy A Schwartzentruber, Omar A Abdul-Rahman, Silke Schlaubitz, David M Murdock, Ming-Ming Jiang, Edward J Lammer, Gregory M Enns, William J Rhead, Jon Rowland, Stephen P Robertson, Valérie Cormier-Daire, Matthew N Bainbridge, Xiang-Jiao Yang, Marie-Claude Gingras, Richard A Gibbs, David S Rosenblatt, Jacek Majewski, Brendan H Lee
Affiliations

Mutations in KAT6B, encoding a histone acetyltransferase, cause Genitopatellar syndrome

Philippe M Campeau et al. Am J Hum Genet. .

Abstract

Genitopatellar syndrome (GPS) is a skeletal dysplasia with cerebral and genital anomalies for which the molecular basis has not yet been determined. By exome sequencing, we found de novo heterozygous truncating mutations in KAT6B (lysine acetyltransferase 6B, formerly known as MYST4 and MORF) in three subjects; then by Sanger sequencing of KAT6B, we found similar mutations in three additional subjects. The mutant transcripts do not undergo nonsense-mediated decay in cells from subjects with GPS. In addition, human pathological analyses and mouse expression studies point to systemic roles of KAT6B in controlling organismal growth and development. Myst4 (the mouse orthologous gene) is expressed in mouse tissues corresponding to those affected by GPS. Phenotypic differences and similarities between GPS, the Say-Barber-Biesecker variant of Ohdo syndrome (caused by different mutations of KAT6B), and Rubinstein-Taybi syndrome (caused by mutations in other histone acetyltransferases) are discussed. Together, the data support an epigenetic dysregulation of the limb, brain, and genital developmental programs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical Presentation of Subjects with GPS Photographs of (A) subject 2 at 9 years of age, (B) subject 3 at 8 years of age, and (C) subject 5 at birth and at 8 months of age.
Figure 2
Figure 2
Hematoxylin and Eosin Images of Tissues from the Autopsy of Subject 3 Tissues shown are (A) the brain (400×) where we show a large cluster of perivascular calcifications in the white matter of the cerebral cortex (arrows point to two of them); these are never present in normal tissue; (B) the pancreas (100×) showing numerous islets of Langerhans, some of which are hyperplastic (black arrows), whereas others are of normal size (red arrows); (C) the kidney (100×), where we show one large and one small subcapsular cyst (arrows), and (D) the severely hypoplastic patella (100×), where there is persistence of the cartilaginous core of the trabeculae (black arrow).
Figure 3
Figure 3
Location of Mutations Identified in KAT6B The five different mutations form a cluster within the C-terminal acidic domain of KAT6B. The 16 coding exons and the corresponding introns of KAT6B are depicted with boxes and solid lines, respectively, with introns not shown to scale. The encoding domains are indicated below the exon-intron organization, along with the corresponding functions. The longest isoform is shown (isoform 1 in uniprot, a.k.a. MORF-beta, CCDS7345, 2073 aa). The following abbreviations are used: H15, histone H1- or H5-like domain; PHD, tandem plant homeodomain-linked zinc fingers. The amino acid changes resulting from five independent mutations present in 6 different subjects are indicated above the schematic exon-intronic structure. The mutations result in C-terminal truncation and remove the transcriptional activation domain, with the resulting mutant impaired in transcriptional activation. Deletions are shown in black arrows, nonsense mutations in green, and the complex insertion-deletion mutation in red. Sequence details of the mutations are shown in Table 3.
Figure 4
Figure 4
Mutant Transcripts Do Not Undergo Nonsense-Mediated Decay (A) Messenger RNA levels of KAT6B, normalized to GAPDH, in lymphoblastoid cell lines derived from subjects 1–4, and from control cell lines (n = 3) (data are represented as mean ± standard error of the mean). (B) Sequencing of cDNA from those cells to demonstrate definitively that the mutant transcripts do not undergo nonsense-mediated decay.
Figure 5
Figure 5
Myst4 Expression in Wild-Type C57BL/6 Mice Detected by Immunohistochemistry Tissues shown are (A) and (B) whole embryos at embryonic day 15.5, (C) femur at postnatal day 1, and (D) kidney at postnatal day 1. The other tissues are at 8 weeks of age: (E) patella, (F) duodenum (which required 2.5 s of exposure time instead of 5), (G) liver, (H) pancreas, (I) spleen, (J) testis, and (K) ovary. Arrows point to the telencephalic vesicles (tv), spinal cord (sc), liver, pancreas, dorsal root ganglia (drg), trigeminal ganglion (tg), ribs, and patella (pat).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abdul-Rahman O.A., La T.H., Kwan A., Schlaubitz S., Barsh G.S., Enns G.M., Hudgins L. Genitopatellar syndrome: Expanding the phenotype and excluding mutations in LMX1B and TBX4. Am. J. Med. Genet. A. 2006;140:1567–1572. - PubMed
    1. Armstrong L., Clarke J.T.R. Report of a new case of “genitopatellar” syndrome which challenges the importance of absent patellae as a defining feature. J. Med. Genet. 2002;39:933–934. - PMC - PubMed
    1. Bergmann C., Spranger S., Javaher P., Ptok M. Genitopatellar syndrome, sensorineural hearing loss, and cleft palate. Oral Maxillofac Surg. 2011;15:103–106. - PubMed
    1. Brugha R., Kinali M., Aminu K., Bridges N., Holder S.E. Genitopatellar syndrome: A further case. Clin. Dysmorphol. 2011;20:163–165. - PubMed
    1. Cormier-Daire V., Chauvet M.L., Lyonnet S., Briard M.L., Munnich A., Le Merrer M. Genitopatellar syndrome: A new condition comprising absent patellae, scrotal hypoplasia, renal anomalies, facial dysmorphism, and mental retardation. J. Med. Genet. 2000;37:520–524. - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts